Home Applications 211045 Application 211045
Type ANDA
Sponsor POLYGEN PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 DARIFENACIN HYDROBROMIDE DARIFENACIN HYDROBROMIDE TABLET, EXTENDED RELEASE;ORAL EQ 7.5MG BASE No No 002 DARIFENACIN HYDROBROMIDE DARIFENACIN HYDROBROMIDE TABLET, EXTENDED RELEASE;ORAL EQ 15MG BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A211045-001 DARIFENACIN HYDROBROMIDE DARIFENACIN HYDROBROMIDE EQ 7.5MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2020-01-06 A211045-002 DARIFENACIN HYDROBROMIDE DARIFENACIN HYDROBROMIDE EQ 15MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2020-01-06
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A211045-001 DARIFENACIN HYDROBROMIDE EQ 7.5MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2020-01-06 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A211045-002 DARIFENACIN HYDROBROMIDE EQ 15MG BASE TABLET, EXTENDED RELEASE / ORAL AB 2020-01-06 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 4 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 52605-067 Darifenacin Darifenacin Hydrobromide POLYGEN PHARMACEUTICALS INC. ANDA Current 52605-067 Darifenacin Darifenacin Hydrobromide Polygen Pharmaceuticals Inc. ANDA Current 52605-068 Darifenacin Darifenacin Hydrobromide POLYGEN PHARMACEUTICALS INC. ANDA Current 52605-068 Darifenacin Darifenacin Hydrobromide Polygen Pharmaceuticals Inc. ANDA Current